NO943988D0 - 7-Disubstituted-methyl-4-oxo-3H, 5H-pyrrolo- (3,2-d) pyrimidine and pharmaceutical uses and preparations containing the same - Google Patents
7-Disubstituted-methyl-4-oxo-3H, 5H-pyrrolo- (3,2-d) pyrimidine and pharmaceutical uses and preparations containing the sameInfo
- Publication number
- NO943988D0 NO943988D0 NO943988A NO943988A NO943988D0 NO 943988 D0 NO943988 D0 NO 943988D0 NO 943988 A NO943988 A NO 943988A NO 943988 A NO943988 A NO 943988A NO 943988 D0 NO943988 D0 NO 943988D0
- Authority
- NO
- Norway
- Prior art keywords
- pyrrolo
- disubstituted
- pyrimidine
- oxo
- methyl
- Prior art date
Links
- KDOPAZIWBAHVJB-UHFFFAOYSA-N 5h-pyrrolo[3,2-d]pyrimidine Chemical compound C1=NC=C2NC=CC2=N1 KDOPAZIWBAHVJB-UHFFFAOYSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/35—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87144192A | 1992-04-21 | 1992-04-21 | |
PCT/US1993/002841 WO1993021187A1 (en) | 1992-04-21 | 1993-03-25 | 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME |
Publications (3)
Publication Number | Publication Date |
---|---|
NO943988D0 true NO943988D0 (en) | 1994-10-20 |
NO943988L NO943988L (en) | 1994-10-20 |
NO303637B1 NO303637B1 (en) | 1998-08-10 |
Family
ID=25357439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO943988A NO303637B1 (en) | 1992-04-21 | 1994-10-20 | 7-Disubstituted-methyl-4-oxo-3H, 5H-pyrrolo-3,2-dipyrimidine, pharmaceutical composition, and use thereof |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0638080A4 (en) |
JP (1) | JPH07507062A (en) |
KR (1) | KR950701335A (en) |
AU (1) | AU4276693A (en) |
CA (1) | CA2133346A1 (en) |
FI (1) | FI944933A (en) |
HU (1) | HUT71559A (en) |
NO (1) | NO303637B1 (en) |
RU (1) | RU94046387A (en) |
WO (1) | WO1993021187A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9809178A (en) * | 1997-05-29 | 2000-08-01 | Novartis Ag | 2-amino-7- (1-substituted-2-hydroxyethyl) -3,5-dihydro-pyrrolo [3,2-d] pyrimidin-4-ones |
US6355244B1 (en) | 1997-11-17 | 2002-03-12 | University Of Kentucky Research Foundation | Methods and compositions for the treatment of psoriasis |
US6174888B1 (en) | 1998-05-28 | 2001-01-16 | Novartis Ag | 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones |
GB0215392D0 (en) * | 2002-07-03 | 2002-08-14 | Glaxo Group Ltd | Chemical compounds |
US7557113B2 (en) | 2003-08-26 | 2009-07-07 | Teijin Pharma Limited | Substituted pyrrolo[3,2-d]pyrimidine derivatives |
JPWO2005019218A1 (en) * | 2003-08-26 | 2006-10-19 | 帝人ファーマ株式会社 | Pyrrolopyrimidinethione derivatives |
MY140748A (en) | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
US7763257B2 (en) | 2004-12-09 | 2010-07-27 | Christina Juneau | Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products |
US8138191B2 (en) | 2007-01-11 | 2012-03-20 | Critical Outcome Technologies Inc. | Inhibitor compounds and cancer treatment methods |
EP2225226B1 (en) | 2007-12-26 | 2016-08-17 | Critical Outcome Technologies, Inc. | Compounds and their use in a method for treatment of cancer |
EP2552915B1 (en) | 2010-04-01 | 2017-07-19 | Critical Outcome Technologies Inc. | Compounds for the treatment of hiv |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2866478B2 (en) * | 1989-10-31 | 1999-03-08 | バイオクリスト・ファーマシューティカルズ・インコーポレイテッド | Purine nucleoside phosphorylase inhibitors |
US5189039A (en) * | 1989-11-29 | 1993-02-23 | Biocryst, Inc. | 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same |
-
1993
- 1993-03-25 CA CA002133346A patent/CA2133346A1/en not_active Abandoned
- 1993-03-25 EP EP93912081A patent/EP0638080A4/en not_active Withdrawn
- 1993-03-25 WO PCT/US1993/002841 patent/WO1993021187A1/en not_active Application Discontinuation
- 1993-03-25 JP JP5518357A patent/JPH07507062A/en active Pending
- 1993-03-25 RU RU94046387/04A patent/RU94046387A/en unknown
- 1993-03-25 KR KR1019940703788A patent/KR950701335A/en not_active Application Discontinuation
- 1993-03-25 AU AU42766/93A patent/AU4276693A/en not_active Abandoned
- 1993-03-25 HU HU9403021A patent/HUT71559A/en unknown
-
1994
- 1994-10-20 FI FI944933A patent/FI944933A/en not_active Application Discontinuation
- 1994-10-20 NO NO943988A patent/NO303637B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0638080A1 (en) | 1995-02-15 |
RU94046387A (en) | 1996-09-27 |
WO1993021187A1 (en) | 1993-10-28 |
JPH07507062A (en) | 1995-08-03 |
KR950701335A (en) | 1995-03-23 |
EP0638080A4 (en) | 1995-08-23 |
FI944933A0 (en) | 1994-10-20 |
FI944933A (en) | 1994-10-20 |
HUT71559A (en) | 1995-12-28 |
AU4276693A (en) | 1993-11-18 |
HU9403021D0 (en) | 1994-12-28 |
NO943988L (en) | 1994-10-20 |
NO303637B1 (en) | 1998-08-10 |
CA2133346A1 (en) | 1993-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO305952B1 (en) | 1,5-benzodiazepine derivatives, their use and pharmaceutical preparations | |
IL89974A0 (en) | Aryl and heteroaryl bicyclodiones,their preparations and their use as herbicides | |
AU8405991A (en) | Pyrimidine derivative and medicine | |
AU7809891A (en) | 2,4-diamino-6-(2-chlorophenyl)pyrimidines and use in medicine | |
PH27460A (en) | Pyrimidine derivatives and herbicidal composition containing the same | |
ZA941993B (en) | Amidine derivatives containing heterocyclic groups the preparation and use thereof | |
DE3677445D1 (en) | 2-SUBSTITUTED-E-CONDENSED (1,5-C) -PYRIMIDINE, PHARMACEUTICAL PREPARATIONS AND THEIR USE. | |
DE59407063D1 (en) | DEODORATING PREPARATIONS | |
DK0385279T3 (en) | Biologically active agents and preparations and materials containing the biologically active agents | |
BR9207062A (en) | Tablet formulation | |
NO943988L (en) | 7-Disubstituted-methyl-4-oxo-3H, 5H-pyrrolo- (3,2-d) pyrimidine and pharmaceutical uses and preparations containing the same | |
DE69429514D1 (en) | ANTIPARASITARY PREPARATIONS | |
AU9044091A (en) | Pharmaceuticals | |
AU5067193A (en) | Pyranoquinolines and their use as pharmaceuticals | |
NO931008D0 (en) | PHARMACEUTICAL RELATIONS | |
BR9605046B1 (en) | n- (pyrimidinyl) -benzenesulfonamide compounds and pharmaceutical preparation containing them. | |
AU8099691A (en) | Pyrimidinyl and triazinyl herbicides | |
DK334989D0 (en) | ANTIVIRAL RELATIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH PRODUCTS. | |
NO951350D0 (en) | Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides | |
NO303392B1 (en) | Polyethers, and their preparation and use | |
ITMI932019A0 (en) | ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING 2-AMINO 4,6-DICHLOROPYRIMIDINE AND METHISOPRINOL | |
NO179907C (en) | Benzoquinoxalines and pharmaceutical preparations containing the same | |
AU7654181A (en) | 5-hydroxy-5h-(1)benzopyranon(4,3-d) pyrimidines and pharmaceutical preparations | |
KR950000305U (en) | Hammock | |
DE59403371D1 (en) | Polyisocyanate preparations |